JoomFish-Language Selection
|
Plan du Site |
- Amylin, Lilly gear up for big FDA ruling
- Cytokinetics gets orphan drug status for ALS drug
- Neuropharm mulls voluntary liquidation as it waits for deal
- EKR names interim president, CEO
- Novartis offers $955M deal to snare Transgene drug option
- Biotech VCs, Big Pharma stepping outside the comfort zone
- In 9-3 vote, expert panel backs InterMune's pirfenidone
- Abbott buys Facet Biotech for $450M
- Tocagen raises $7.8M; ISTA gets PDUFA date;
- AutoImmune calls it quits
